Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Nopora

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Genomics & Proteomics|October 30, 2019
Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical <i>In Vivo</i> ModelsUlrich H Weidle, Fabian Birzele, Adam Nopora
Cancer Genomics & Proteomics|March 10, 2019
MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung CancerUlrich H Weidle, Fabian Birzele, Adam Nopora
Cancer Genomics & Proteomics|January 9, 2021
microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical PrognosisUlrich H Weidle, Fabian Birzele, Adam Nopora
Cancer Genomics & Proteomics|December 25, 2017
Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer MetastasisUlrich H Weidle, Fabian Birzele, Gwen Kollmorgen, et al.
Cancer Research|July 11, 2012
Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonistStefan Weigand, Frank Herting, Daniela Maisel, et al.
Plos One|July 28, 2016
Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft ModelDaniela Maisel, Fabian Birzele, Edgar Voss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2015
CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer PatientsFabian Birzele, Edgar Voss, Adam Nopora, et al.
Blood|March 3, 2010
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicityEkkehard Mössner, Peter Brünker, Samuel Moser, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Genomics & Proteomics|October 30, 2019
Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical <i>In Vivo</i> ModelsUlrich H Weidle, Fabian Birzele, Adam Nopora
Cancer Genomics & Proteomics|March 10, 2019
MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung CancerUlrich H Weidle, Fabian Birzele, Adam Nopora
Cancer Genomics & Proteomics|January 9, 2021
microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical PrognosisUlrich H Weidle, Fabian Birzele, Adam Nopora
Cancer Genomics & Proteomics|December 25, 2017
Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer MetastasisUlrich H Weidle, Fabian Birzele, Gwen Kollmorgen, et al.
Cancer Research|July 11, 2012
Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonistStefan Weigand, Frank Herting, Daniela Maisel, et al.
Plos One|July 28, 2016
Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft ModelDaniela Maisel, Fabian Birzele, Edgar Voss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2015
CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer PatientsFabian Birzele, Edgar Voss, Adam Nopora, et al.
Blood|March 3, 2010
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicityEkkehard Mössner, Peter Brünker, Samuel Moser, et al.
Pageof 2